Technology with purpose.

Attackers can register domains one letter off your brand, stand up web or mail infrastructure, and use that confusion to target customers, vendors, finance teams, or employees. Vendors you trust may operate email infrastructure with gaps that make impersonation easier. These are practical, observable risks that standard workflows often miss.

Social engineering, business email compromise, and impersonation remain persistent business risks. Many tools focus on monitoring dashboards, self-reported questionnaires, or internal controls; MOORLI focuses on point-in-time outside-in evidence that a buyer, MSP, or leadership team can review quickly.

MOORLI builds diagnostic engines—automated outside-in audits that assess specific observable risk signals and deliver clear, actionable evidence. No subscriptions. No credentials or vendor cooperation required.

MOORLI BrandGuardDiagnostic generates and ranks high-relevance typosquat and lookalike candidates for your brand domain, then evaluates the highest-priority candidates in your plan across 36 rules in 9 categories using selected external corroboration signals plus observable DNS, registration, web, mail, and TLS signals available at scan time.

MOORLI VendorRiskDiagnostic assesses up to 100 vendor domains in a single point-in-time scan across 42 rules in 6 categories using public DNS, lightweight public-web validation where relevant, registration context, and selected external corroboration signals used as supporting inputs. Findings roll into 4 scored report pillars: Spoofing, Identity, Transport, and Infrastructure.

Both are provider-agnostic and outside-in by design.

We never ask for admin access, questionnaires, or vendor cooperation. We examine public DNS records, registration context, lightweight public-web signals where relevant, and selected external corroboration inputs—the same public-facing evidence an attacker can inspect. Findings are formatted for leadership, technical teams, and MSPs, with deliverables based on the selected tier.